Liwang Cui Selected Research

Vivax Malaria

12/2023	Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
12/2023	Factors hindering coverage of targeted mass treatment with primaquine in a malarious township of northern Myanmar in 2019-2020.
10/2023	Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
10/2023	Interventions for promoting patients' adherence to 14-day primaquine treatment in a highly malaria-endemic township in Myanmar: a qualitative study among key stakeholders.
9/2023	Interventions for promoting patients' adherence to 14-day primaquine treatment in a highly malaria-endemic township in Myanmar: A qualitative study among key stakeholders.
2/2023	Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
6/2022	Genetic diversity of Plasmodium vivax reticulocyte binding protein 2b in global parasite populations.
6/2022	Therapeutic efficacy of chloroquine for uncomplicated Plasmodium vivax malaria in southeastern and western border areas of Myanmar.
10/2021	The acceptability of targeted mass treatment with primaquine for local elimination of vivax malaria in a northern Myanmar township: a mixed-methods study.
7/2020	Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liwang Cui Research Topics

Disease

140	Malaria 04/2024 - 11/2002
35	Infections 12/2023 - 08/2003
20	Vivax Malaria 12/2023 - 04/2006
13	Falciparum Malaria (Plasmodium falciparum Malaria) 03/2024 - 10/2008
11	Glucosephosphate Dehydrogenase Deficiency 12/2023 - 03/2012
7	Hemolysis 05/2023 - 11/2013
6	Cerebral Malaria 01/2024 - 08/2012
6	Parasitemia 01/2023 - 05/2013
2	Bites and Stings (Sting) 10/2023 - 09/2023
2	Anemia 02/2023 - 01/2020
2	Asymptomatic Infections 08/2020 - 02/2015
2	Parasitic Diseases (Parasitic Disease) 02/2019 - 05/2013
2	Acute malaria 01/2015 - 08/2012
1	Hemolytic Anemia 02/2023
1	Dengue (Dengue Fever) 11/2022
1	Reinfection 06/2022
1	Fever (Fevers) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Hemoglobinopathies 11/2018

Drug/Important Bio-Agent (IBA)

32	VaccinesIBA 03/2024 - 03/2006
25	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2004
24	artemisinin (artemisinine)IBA 02/2024 - 03/2012
22	Antimalarials (Antimalarial Agents)IBA 04/2024 - 03/2006
20	Primaquine FDA Link 12/2023 - 03/2012
19	AntigensIBA 01/2023 - 09/2006
10	InsecticidesIBA 10/2023 - 03/2012
7	Chloroquine (Aralen)FDA LinkGeneric 12/2023 - 08/2012
7	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 05/2023 - 01/2015
7	AntibodiesIBA 01/2020 - 04/2006
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2004
6	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 09/2009
5	EnzymesIBA 05/2023 - 11/2005
4	Histones (Histone)IBA 04/2024 - 03/2006
4	artenimol (dihydroartemisinin)IBA 11/2022 - 09/2015
4	Inosine Diphosphate (IDP)IBA 07/2018 - 07/2015
4	ArtesunateIBA 10/2017 - 11/2015
4	Merozoite Surface Protein 1 (MSA1)IBA 07/2017 - 01/2013
3	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 03/2024 - 08/2020
3	naphthoquineIBA 12/2022 - 01/2018
3	piperaquineIBA 11/2022 - 09/2015
3	Recombinant ProteinsIBA 06/2022 - 08/2011
3	Pyrethrins (Pyrethroids)FDA Link 01/2020 - 01/2013
3	Indicators and Reagents (Reagents)IBA 02/2019 - 11/2016
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2010 - 11/2002
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2023 - 01/2023
2	ChromatinIBA 10/2023 - 08/2010
2	MethyltransferasesIBA 01/2023 - 01/2023
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 01/2022
2	Azithromycin (Zithromax)FDA LinkGeneric 10/2021 - 01/2018
2	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2021 - 11/2010
2	Folic Acid AntagonistsIBA 08/2020 - 03/2005
2	Hemoglobin EIBA 11/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 10/2017
2	Erythropoietin FDA Link 07/2017 - 01/2014
2	ProteomeIBA 01/2017 - 08/2011
2	ArtemisininsIBA 01/2016 - 12/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2012 - 02/2012
2	Nucleosomes (Nucleosome)IBA 03/2012 - 04/2004
1	clothianidinIBA 01/2024
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 12/2023
1	Surface Antigens (Surface Antigen)IBA 11/2023
1	16S Ribosomal RNAIBA 04/2023
1	antineoplaston A10 (A 10)IBA 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Immune Sera (Antisera)IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	CytosineIBA 01/2023
1	Alprostadil (Muse)FDA LinkGeneric 12/2022
1	Lumefantrine FDA Link 12/2022
1	Pyrimethamine (Daraprim)FDA Link 12/2022
1	pyronaridineIBA 12/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2022
1	bendiocarbIBA 11/2022
1	N-methylchlorphentermineIBA 10/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 06/2022
1	Plasmodium vivax reticulocyte-binding proteinIBA 06/2022
1	decamethrin (deltamethrin)IBA 05/2022
1	alexidineIBA 01/2022
1	TabletsIBA 10/2021
1	Mitochondrial DNA (mtDNA)IBA 09/2021
1	Oxidoreductases (Dehydrogenase)IBA 06/2021
1	Glucose (Dextrose)FDA LinkGeneric 06/2021
1	Codon (Codons)IBA 08/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 08/2019
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 08/2019
1	Bile Pigments (Bilin)IBA 02/2019
1	CRISPR-Associated Protein 9IBA 01/2019
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2019
1	protein phosphatase 5IBA 01/2019
1	LigandsIBA 01/2019
1	p 230 (p230)IBA 10/2018
1	Nucleic AcidsIBA 09/2018
1	Amino Acids FDA Link 01/2018

Therapy/Procedure

17	Therapeutics 02/2024 - 03/2012
3	Aftercare (After-Treatment) 02/2023 - 09/2015
1	Treatment Delay 01/2024
1	Bathroom Equipment 01/2021